WT1 and leukemia: This study proved the suppressing effect of shikonin on WT1 in protein expression and function and suggested that: (1) shikonin can down-regulate the WT1 protein level for leukemia differentiation therapy, and (2) the interaction between WT1 and CD34 proteins may be responsible for granulocyte/monocyte immaturity in HL-60 cells.